Ahmedabad: Pankaj Patel, Chairman of Gujarat headquartered Cadila Healthcare, the fifth largest pharmaceutical company in India today in an interview said his company would soon start phase-1-2 study on Covid-19 vaccine involving 1,000 volunteers, results of which could be out in around three months.
The Drug Controller General of India (DCGI) had yesterday granted permission to Zydus Cadila to conduct phase I and phase II human clinical trials for COVID -19 vaccine in a rapid response after...Read More